Position in AZN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$134,978,154
New position
Shares Held
684,404
first reported quarter
Ownership
0.044%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 80.12431254054623.ToString("F0")%
Shared 0.0073056265013062465.ToString("F0")%
None 19.868381832952466.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026STIFEL FINANCIAL CORP holds $5,042,614,731 across 16 Drug Manufacturers - General names. AZN ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,489,121 | $1,097,320,733 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,291,826 | $997,423,745 | |
| 3 | ABBV |
AbbVie Inc.
|
3,732,204 | $811,717,043 | |
| 4 | LLY |
ELI LILLY & Co
|
779,157 | $716,645,230 | |
| 5 | AMGN |
Amgen Inc
|
1,555,021 | $547,134,134 | |
| 6 | PFE |
Pfizer Inc
|
9,769,180 | $274,318,571 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,202,321 | $167,567,475 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
684,404 | $134,978,154 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $134,978,154 | 684,404 | Shares | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||